Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events trial. This trial showed a modest benefit in the reduct...
Salvato in:
| Pubblicato in: | Curr Control Trials Cardiovasc Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2000
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59615/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714429/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-1-3-143 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|